Abstract
In aquatic invertebrates, hemolymph is critical for host–environment interaction. Although maintaining microbial homeostasis in hemolymph is significant for disease pathogenesis, the key regulatory mechanisms remain elusive. This study investigates the essential role of the respiratory glycoprotein hemocyanin (HMC) in modulating hemolymph microbial composition in penaeid shrimp. Hemocyanin-depleted shrimp infected with Vibrio parahaemolyticus (Vp) exhibited disruptions in the niacinamide (NAM) salvage pathway, attenuated plasma niacinamide and nicotinamide adenine dinucleotide (NAD) levels, and reduced transcripts of key enzymes. These alterations correlated with an increased total bacterial load and a higher abundance of opportunistic pathogens like Vibrio and Shewanella. Hemocyanin likely modulates niacinamide metabolism through interactions with Litopenaeus vannamei nicotinamide riboside kinase 1 (LvNRK1), sirtuin 2 (LvSIRT2), and sirtuin 6 (LvSIRT6). Remarkably, niacinamide supplementation after hemocyanin knockdown restored hemolymph microbial balance, reduced Vibrio dominance, and improved shrimp survival against V. parahaemolyticus infection, but not Gram-positive Staphylococcus aureus (Sa). These findings provide novel insights into the pivotal role of niacinamide metabolism in regulating shrimp hemolymph microbial composition via hemocyanin.
Keywords: hemolymph microbial homeostasis, niacinamide, respiratory proteins, hemocyanin, shrimp
Introduction
Most animals harbor diverse microbial communities that contribute to nutrition, immune defense, and disease control [1–3]. Host-associated microbiota forms a dynamic microenvironment shaped by long-term interactions between the host and environmental microorganisms [4, 5]. In vertebrates, microbiota mainly colonize body surfaces and cavities connected to the external environment, such as the skin and gut [6]. Although blood was traditionally regarded as sterile [7], the discovery of blood microbiota and circulating microbial metabolites has expanded our understanding of host–microbe interactions in internal body compartments [8]. These circulating microbes and metabolites have been implicated in immune surveillance and a range of inflammatory and metabolic disorders [9, 10].
Aquatic environments harbor highly diverse and dynamic bacterial communities [11]. Therefore, in aquatic organisms with a semi-open circulatory system, hemolymph represents a critical host–environment interface and must maintain microbial homeostasis despite continuous exposure to environmental microorganisms [12]. In mollusks and crustaceans, many hemolymph-associated bacteria are opportunistic pathogens, yet under normal conditions they are maintained in a relatively stable state rather than causing septic disease [13–15]. As the main circulatory fluid in invertebrates, hemolymph and its microbiota are thus crucial for host immunity and disease susceptibility [16]. In aquatic invertebrates, hemolymph bacteria are largely derived from the environment [17]. Because these animals lack adaptive immunity mediated by antibodies and T/B cells, they rely mainly on innate immune mechanisms, including humoral responses, phagocytosis, encapsulation, and nodulation [18, 19]. Accordingly, the hemolymph contains numerous antibacterial effectors, including antimicrobial peptides, lectins, and other active molecules that influence microbial composition [20]. This controlled interaction with resident microbes may also contribute to immune preparedness against invading pathogens [21].
Niacinamide (NAM), an amide derivative of vitamin B3, is a key precursor of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) and is essential for cellular energy metabolism and homeostasis [22–24]. As an important substrate cycle intermediate, NAD supports the activity of enzymes such as sirtuins, poly (ADP-ribose) polymerases (PARP), and CD38, thereby linking niacinamide metabolism to multiple aspects of cellular regulation [25, 26]. In addition to its metabolic role, niacinamide has important immunomodulatory functions. It can inhibit biofilm formation of Propionibacterium acnes and suppress P. acnes–induced IL-8 production in keratinocytes through the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways [27]. Niacinamide also replenishes NAD and adenosine triphosphate (ATP); protects cells against oxidative stress, apoptosis, and necrosis; and enhances antimicrobial peptide expression in intestinal epithelial cells [28–30]. However, whether niacinamide metabolism contributes to hemolymph microbiota homeostasis in aquatic invertebrates remains unknown.
Penaeid shrimp, particularly the Pacific white shrimp (Litopenaeus vannamei), is the most widely farmed aquaculture species worldwide, yet bacterial diseases such as Vibrio-associated acute hepatopancreatic necrosis disease (AHPND) have caused major economic losses [31]. Disease onset in shrimp is often accompanied by microbial dysbiosis, especially enrichment of pathogenic Vibrio species [32–34]. As an intermediary between the host and its semi-open environment, hemolymph plays an important role in maintaining microbial homeostasis and thereby influences shrimp health and immunity [15]. Recent studies have shown that several hemolymph components, including C-type lectins and FOXO, actively regulate hemolymph microbial homeostasis [20, 35, 36]. Hemocyanin (HMC), the major respiratory protein in arthropods and mollusks, accounts for >90% of the soluble proteins in shrimp hemolymph [37] and is increasingly recognized as a multifunctional immune-related factor [38], including roles in shaping microbial composition in the shrimp hepatopancreas [39]. Therefore, given its abundance and immune relevance in hemolymph, we asked whether hemocyanin regulates hemolymph microbiota. Here, we show that during Vibrio parahaemolyticus (Vp) infection, hemolymph hemocyanin modulates niacinamide levels to shape microbial composition and distribution. These findings provide new insight into how host factors coordinate immunometabolism and microbial homeostasis in penaeid shrimp.
Materials and methods
Experimental animals, bacteria, and ethics
Healthy and diseased Pacific white shrimp (L. vannamei; 7 ± 0.5 g) were obtained from Fuzeng Aquaculture Co., Ltd. (Shanwei, Guangdong, China). Diseased shrimp showed typical hepatopancreatic atrophy and an empty gastrointestinal tract (GIT). Hemolymph from five shrimp was pooled as one biological sample (n = 6), collected from the ventral sinus into pre-cooled anticoagulant, and separated for DNA, RNA, and protein analyses. Hemocytes and hemolymph-associated bacterial pellets were collected by differential centrifugation for nucleic acid extraction, whereas hemocyte pellets or plasma were used for protein and metabolite analyses. A separate batch of healthy shrimp (5–8 g) from Huaxun Aquatic Product Corporation (Shantou, Guangdong, China) was acclimated in aerated artificial seawater (salinity 10‰, 23–26°C) for 2–3 days, fed a commercial diet twice daily, and fasted for 24 h before experiments. All animal experiments were approved by the Animal Research and Ethics Committee of Shantou University and conducted in accordance with institutional guidelines. No human participants were involved.
Vibrio parahaemolyticus (MCCC1H00057; GenBank FJ161313.1) and Shewanella basaltis (MCCC 1A00286; GenBank NR_044418.1) were obtained from the Marine Culture Collection of China and cultured at 30°C in Tryptic Soy Broth (TSB) and 2216E medium, respectively. Staphylococcus aureus (Sa), previously isolated from penaeid shrimp in our laboratory, was cultured in Luria–Bertani (LB) medium.
Hemocyanin knockdown and bacterial challenge
Double-stranded RNAs (dsRNA) targeting L. vannamei hemocyanin (dsLvHMC; GenBank XM_027383261.1) or green fluorescent protein (dsGFP; GenBank U55762.1) were synthesized using T7 promoter-linked primers and the HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB, USA). Shrimp were injected intramuscularly with dsLvHMC or dsGFP (10 μg per shrimp) every 24 h. At 48 h after the first dsRNA injection, shrimp received V. parahaemolyticus (2 × 105 colony-forming units (CFU)/shrimp) or sterile 0.65% saline. Knockdown efficiency was assessed by quantitative real-time polymerase chain reaction (qPCR) and Western blot at 24 h post-challenge. Hemolymph was collected from 30 shrimp per group and divided for DNA, RNA, and protein analyses. For metabolomics, plasma from 30 shrimp per group was collected into an equal volume of pre-cooled 0.1 M ethylenediaminetetraacetic acid (EDTA) (pH 7.2) and clarified by centrifugation to remove hemocytes and bacteria.
RNA and DNA extraction and qPCR
Total RNA from hemocytes and genomic DNA from hemolymph-associated bacteria were extracted using TRIzol Plus RNA Purification Kit (Invitrogen, USA) and TIANamp Marine Animals DNA Kit (TIANGEN, China), respectively. Sample quantity and integrity were assessed using a NanoDrop 2000 spectrophotometer (Thermo, USA), Agilent 2100 Bioanalyzer (Agilent, USA), and agarose gel electrophoresis. First-strand cDNA was synthesized using EasyScript One-Step gDNA Removal and cDNA Synthesis SuperMix (TransGen Biotech, China).
Relative qPCR was performed with gene-specific primers (Table S1), using elongation factor 1 alpha (LvEF-1α) as the internal control and the 2−ΔΔCT method. Absolute qPCR for bacterial quantification used gDNA templates and strain-specific standard curves. Primers targeted total bacteria, Vibrio spp., Shewanella spp., and S. aureus rpoB (Table S1). Reactions were performed with 2× RealStar SYBR Green Mix (Genstar, China) on a qTOWER3G system (Analytik Jena, Germany). PCR-based identification of Vibrio spp. used tlh, PirB, and Vhh primers (Table S1). Each assay included three technical replicates.
Protein extraction and Western blotting
Hemolymph from hemocyanin-knockdown and control shrimp, with or without V. parahaemolyticus challenge, was separated into plasma and hemocyte fractions. Hemocytes were lysed in cold NP-40 lysis buffer and clarified by centrifugation. Plasma and lysates were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to PVDF membranes (Millipore, USA), blocked with 5% skim milk in TBST, and incubated with rabbit anti-shrimp hemocyanin antibody or mouse anti-α-tubulin antibody (Sigma-Aldrich, USA), followed by horseradish peroxidase (HRP)-conjugated secondary antibodies (Thermo, USA). Signals were detected using enhanced chemiluminescence (ECL) on an Amersham Imager 600 (GE Healthcare, USA). Band intensities were quantified using ImageJ 1.46r (NIH, USA) and normalized to α-tubulin.
Untargeted metabolomics and data processing
Plasma metabolites were extracted from 100 μl plasma using acetonitrile/methanol (1:1, v/v) containing L-2-chlorophenylalanine as an internal standard. After sonication, protein precipitation, centrifugation, drying, and reconstitution, supernatants were analyzed by liquid chromatography-tandem mass spectrometry (LC–MS/MS). Pooled quality control (QC) samples were prepared by mixing equal volumes of all extracts and injected every 10 runs.
LC–MS/MS was performed on a Thermo UHPLC-Q Exactive HF-X system equipped with an ACQUITY HSS T3 column (100 × 2.1 mm, 1.8 μm). Data-dependent acquisition was conducted in both positive and negative electrospray ionization modes over an m/z range of 70–1050. Raw data were processed using Progenesis QI (Waters, USA), with internal standard peaks and known false-positive features removed. Metabolites were annotated against Human Metabolome Database (HMDB), Metlin, and Majorbio databases. The resulting matrix was processed on the Majorbio Cloud platform by retaining features present in at least 80% of samples, imputing low-abundance values with the minimum value, applying sum normalization, excluding QC variables with relative standard deviation (RSD) >30%, and log10-transforming intensities. Partial least squares discriminant analysis (PLS-DA) and seven-cycle cross-validation were performed using the R package ropls (v1.6.2). Differential metabolites were defined as variable importance in projection (VIP) >1 and P <.05 by Student’s t-test. Raw metabolomics data are available in MetaboLights under accession MTBLS8272.
Targeted metabolite and enzyme assays
Niacinamide levels in shrimp plasma were measured using an enzyme-linked immunosorbent assay (ELISA) kit (Boshen Biotechnology, China), and NAD levels were quantified using a Coenzyme I NAD(H) Assay Kit (Solarbio, China), following the manufacturers’ protocols. Absorbance was measured with a BioTek Synergy H1 microplate reader (USA). All assays were performed with technical triplicates and three independent biological replicates.
Hemocyanin was purified from shrimp plasma by gel filtration chromatography on an AKTA pure system (GE, USA), and hemocyanin-containing fractions were verified by SDS–PAGE and Western blot. GST-tagged LvNRK1 (XM_027351750.1), LvSIRT2 (XM_027358632.1), and LvSIRT6 (XM_027372938) were cloned into pGEX-6p-1 using the ClonExpress II One Step Cloning Kit (Vazyme, China), expressed as fusion proteins, and incubated with purified hemocyanin at 4°C for GST pull-down analysis. Bound proteins were washed, resolved by SDS–PAGE, and analyzed by Western blotting; 5% input protein was used as a loading control.
NRK1 activity after hemocyanin interaction was estimated from the conversion of nicotinamide riboside (NR) to nicotinamide mononucleotide (NMN). Reaction mixtures containing Tris–HCl, MgCl2, ATP, nicotinamide riboside and purified NRK1, hemocyanin, or NRK1–hemocyanin complexes were incubated at 30°C for 30 min, terminated by boiling, and analyzed using an NMN ELISA kit (Boshen Biotechnology, China). Relative NRK1 activity was calculated as the molar conversion rate of nicotinamide riboside to NMN. SIRT2 and SIRT6 activities after hemocyanin interaction were measured using the Epigenase Universal SIRT Activity/Inhibition Assay Kit (EpigenTek, USA) with trichostatin A to suppress histone deacetylase (HDAC) I/II interference. Fluorescence was measured at 530/590 nm (excitation/emission), and activity was calculated from the standard curve as ng/min/mg protein.
16S rRNA gene sequencing and microbial community analysis
Hemolymph bacterial DNA was sent to Majorbio Bio-Pharm Technology Co., Ltd. (Shanghai, China) for 16S ribosomal ribonucleic acid (16S rRNA) gene sequencing. The V3–V4 region was amplified using primers 338F/806R (Table S1), purified, pooled in equimolar amounts, and sequenced on an Illumina PE300/250 platform. Raw reads were deposited in the NCBI Sequence Read Archive (SRA) under BioProject PRJNA988426.
Raw reads were demultiplexed, quality-filtered using fastp (v0.19.6), and merged using FLASH (v1.2.7). Operational taxonomic units (OTUs) were clustered at 97% similarity using UPARSE (v7.1), and representative sequences were taxonomically assigned using the RDP Classifier (v2.2) against the SILVA v138 database with a confidence threshold of 0.7. Samples were rarefied to 20 000 reads before diversity analysis. Rarefaction curves, observed OTUs, Chao1 richness, Shannon index, and Good’s coverage were calculated with Mothur (v1.30.1). Principal coordinate analysis (PCoA) based on Bray–Curtis dissimilarity was performed using the R package vegan (v2.5-3) on the Majorbio Cloud platform.
Niacinamide supplementation and survival assays
For niacinamide supplementation, shrimp were injected with dsLvHMC or dsGFP as described above. At 48 h after knockdown, shrimp received 100 μl niacinamide (0.33 mM) or vehicle control, followed 24 h later by V. parahaemolyticus, S. aureus (2 × 105 CFU per shrimp), or sterile saline. Hemolymph from five shrimp per group was collected for bacterial 16S rRNA gene sequencing and qPCR analysis. Survival was monitored for 96 h after niacinamide injection or 48 h after bacterial challenge.
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM) unless otherwise indicated. Statistical analyses were performed using SPSS v20.0, GraphPad Prism v8.0.1 and the Majorbio Cloud platform. Differences between two groups were assessed using an unpaired two-tailed Student’s t-test when data met assumptions of normality and equal variance. Kaplan–Meier survival curves were compared using the log-rank (Mantel–Cox) test. Pearson correlation, linear regression, and Spearman correlation analyses were applied where appropriate. P <.05 was considered statistically significant.
Results
Shrimp plasma metabolites profile changes with hemocyanin levels
Given that hemolymph hemocyanin levels affect various metabolic processes in Penaeus shrimp [39, 40], we examined plasma metabolite profiles after hemocyanin knockdown with or without V. parahaemolyticus challenge (dsLvHMC + Vp vs dsGFP + Vp; dsLvHMC + Ns vs dsGFP + Ns). Hemocyanin knockdown in hemocytes and plasma was confirmed (Fig. 1A–C). Untargeted metabolomics revealed marked changes in plasma metabolites, with 142 differential metabolites identified across the four groups (Table S2; Fig. 1D). Most belonged to lipids and lipid-like molecules (40.85%), followed by amino acids and derivatives (16.90%), benzenoids (11.97%), and organic nitrogen compounds (10.56%).
Figure 1.
Global metabolic profiles of penaeid shrimp plasma after hemocyanin knockdown under physiological and pathological conditions. (AB) Hemocyanin expression in shrimp hemocytes determined by (A) qPCR and (B) Western blot (WB) analysis after dsRNA-mediated knockdown. (C) Hemocyanin protein expression in shrimp plasma after dsRNA-mediated knockdown determined by WB. (D) Metabolite categories analyzed by heatmap (n = 6). (E) Partial least squares discriminant analysis (PLS-DA) based on Bray–Curtis distance. (F–H) Heatmaps showing significantly dysregulated metabolites in the plasma of (F) dsGFP + Ns vs dsLvHMC + Ns shrimp, (G) dsGFP + Vp vs dsLvHMC + Vp shrimp, and (H) dsGFP + Ns vs dsGFP + Vp shrimp. (I) Significantly changed metabolite categories identified from the volcano plots and analyzed by heatmap. The heat map scale represents relative metabolite abundance from low to high levels (n = 6).
PLS-DA showed clear separation among groups (Fig. 1E). Based on OPLS-DA, VIP ≥1, and t-test (P ≤ .05), 33 differential metabolites were identified in dsLvHMC + Ns versus dsGFP + Ns, 7 in dsLvHMC + Vp versus dsGFP + Vp, and 32 in dsGFP + Vp versus dsGFP + Ns (Fig. 1F–H). These significantly dysregulated metabolites were grouped into eight categories, again dominated by lipids and lipid-like molecules, followed by amino acids and derivatives (Fig. 1I).
Hemocyanin levels affect niacinamide metabolism
To identify metabolites consistently associated with hemocyanin under physiological and pathological conditions, we compared dsLvHMC + Ns and dsLvHMC + Vp with their respective controls and obtained six shared differential metabolites (Fig. 2A). Among them, niacinamide showed the strongest association with hemocyanin expression. Hemocyte hemocyanin levels were positively correlated with plasma niacinamide in dsGFP + Ns, dsLvHMC + Ns, and dsGFP + Vp, but negatively correlated in dsLvHMC + Vp (Fig. 2B). ELISA and LC–MS/MS further confirmed that hemocyanin knockdown significantly reduced niacinamide levels, particularly after pathogen challenge (Fig. 2C and D).
Figure 2.
Niacinamide metabolism is dysregulated in shrimp hemolymph after hemocyanin knockdown under pathological conditions. (A) Hemocyanin-related metabolites were analyzed by heatmap (n = 6). (B) Heatmap showing the correlation between hemocyte hemocyanin levels and hemocyanin-related metabolites abundance in shrimp plasma determined. Statistical significance is indicated by asterisks (*P < .05, **P < .01, ns means not significant). The plus sign represents positive correlation and the minus sign represents negative correlation. (C) Shrimp plasma niacinamide level determined by ELISA. (D) Violin diagram showing the differential expression of niacinamide in shrimp plasma determined by GC–MS analysis. (E) Shrimp plasma NAD level determined by ELISA. (F) Schematic diagram showing changes in niacinamide salvage pathway–related enzymes at the transcriptional level in shrimp hemocytes after hemocyanin knockdown under physiological and pathological conditions. (GH) Immunoblots of protein–protein interaction analysis between (G) LvHMC and GST-LvNRK1 or (H) LvHMC, GST-LvSIRT2, and GST-LvSIRT6. (I) Relative enzymatic activity of LvNRK1 [expressed as the conversion rate of nicotinamide riboside (NR) to nicotinamide mononucleotide (NMN)] under 0.5 mM NR substrate condition following interaction with LvHMC. (J) Enzymatic activity of LvSIRT2 and LvSIRT6 following interaction with LvHMC. Each dot represents an independent sample (n = 6), and results were reported as mean ± SEM. *P < .05, **P < .01.
We next examined key enzymes in the niacinamide salvage pathway. Under V. parahaemolyticus challenge, hemocyanin knockdown significantly reduced the hemocyte transcript levels of NRK1/2, NMNAT, ENPP1, SIRT2, and SIRT6, and also decreased plasma NAD levels (Fig. 2E and F). Pull-down assays showed that LvHMC interacted with LvNRK1, LvSIRT2, and LvSIRT6 (Fig. 2G and H). These interactions significantly enhanced LvNRK1 catalytic conversion of NR to NMN, as well as LvSIRT2 and LvSIRT6 enzymatic activities (Fig. 2I and J). Together, these results indicate that hemocyanin regulates niacinamide metabolism during pathogen challenge.
Hemolymph microbiota composition is modulated by hemocyanin levels
Given the effect of hemocyanin on niacinamide metabolism, we next analyzed hemolymph microbiota by 16S rRNA sequencing in healthy and diseased shrimp collected from the same pond. At the genus level, diseased shrimp showed a markedly higher relative abundance of Vibrio than healthy shrimp (21.27% vs 8.71%; Fig. 3A), and qPCR confirmed significantly higher absolute Vibrio abundance in diseased shrimp (Fig. 3B). Among the pathogen-specific markers tested, only the tlh gene of V. parahaemolyticus was significantly elevated in diseased shrimp, whereas pirB and vhh did not differ significantly (Fig. 3C–E). Diseased shrimp also exhibited lower hemocyte hemocyanin transcript levels, which were negatively correlated with hemolymph Vibrio abundance (Fig. 3F and G). In addition, diseased shrimp had lower total hemocyte counts and lower plasma niacinamide levels than healthy shrimp (Fig. 3H and I).
Figure 3.
Hemocyanin level affects microbial composition and Vibrio abundance in the hemolymph of penaeid shrimp. (A) Community bar plot of proportions of bacteria taxa in the hemolymph of healthy and diseased penaeid shrimp at genus level (n = 3). (B–F) PCR-based quantification of the 16S rRNA gene in shrimp hemolymph including (B) Vibrio abundance, (C) V. parahaemolyticus (tlh), (D) V. parahaemolyticus (AHPND) (pirB), and (E) V. harveyi (vhh). (F) Hemocyanin transcript levels in hemocytes. (G) Correlation between hemocytes hemocyanin transcript levels and Vibrio abundance in the hemolymph of healthy and diseased shrimp. (H) Total hemocyte counts in the hemolymph of healthy and diseased shrimp. (I) Relative abundance of niacinamide in shrimp plasma determined by ELISA. (JK) Hemolymph microbial community diversity at the OTU level after hemocyanin knockdown under physiological conditions and pathogen challenge conditions determined using (J) Shannon diversity index and (K) principal coordinates analysis (PCoA). (L–N) The quantification of the (L) total bacterial abundance, (M) Vibrio abundance, (N) Shewanella abundance after dsRNA (dsGFP or dsLvHMC) injection by qPCR. (O) Correlation between hemocyte hemocyanin levels and the abundance of total bacterial abundance, Vibrio abundance, and Shewanella analyzed by heatmap. Dots represent independent biological samples. Results were reported as mean ± SEM (n = 6). Statistical significance is indicated by asterisks (*P < .05, **P < .01, ns means not significant).
We then examined the effect of hemocyanin knockdown on hemolymph microbiota with or without pathogen challenge. Shannon diversity decreased significantly after V. parahaemolyticus challenge in both control and hemocyanin-silenced shrimp, and also declined in dsLvHMC + Ns relative to dsGFP + Ns (Fig. 3J). PCoA showed distinct bacterial communities among the four groups (Fig. 3K). Under pathogen challenge, hemocyanin knockdown significantly increased total bacterial abundance as well as the relative abundances of Vibrio and Shewanella (Fig. 3L–N). Hemocyte hemocyanin transcript levels were negatively correlated with total bacteria, Vibrio, and Shewanella abundance (Fig. 3O), indicating that reduced hemocyanin favors the expansion of opportunistic pathogens during V. parahaemolyticus infection.
Correlation analysis between dysregulated metabolites and altered bacterial taxa further showed that, after hemocyanin knockdown and V. parahaemolyticus stimulation, niacinamide was negatively correlated with Vibrio, Rheinheimera, Shewanella, and Flavobacterium, with the strongest association observed for Vibrio (Fig. S1).
Hemolymph microbiota composition is modulated by hemocyanin via niacinamide metabolism during Vibrio challenge
To test whether hemocyanin regulates hemolymph microbiota through niacinamide, hemocyanin-silenced shrimp were supplemented with niacinamide and then challenged with V. parahaemolyticus (Fig. 4A). 16S rDNA sequencing showed distinct bacterial communities among the four treatment groups (Fig. 4B). In hemocyanin-silenced shrimp without niacinamide supplementation, Vibrio became the dominant genus (32.14%), whereas niacinamide supplementation reduced its proportion to 12.64% (Fig. 4C). Niacinamide also significantly increased bacterial alpha diversity in hemocyanin-silenced shrimp after V. parahaemolyticus challenge (Fig. 4D), and PCoA revealed clear group separation (Fig. 4E). Consistently, qPCR showed that niacinamide supplementation reduced total bacterial abundance and the relative abundances of Vibrio and Shewanella in hemocyanin-silenced shrimp (Fig. 4F–H). The reduced plasma NAD level caused by hemocyanin knockdown was also restored by niacinamide supplementation (Fig. 4I).
Figure 4.
Niacinamide supplementation shapes the hemolymph microbiota in Vibrio-infected shrimp. (A) Exogenous treatment of L. vannamei with or without niacinamide (NAM) after depleting hemocyanin followed by V. parahaemolyticus (Vp) infection. (BC) Relative bacteria abundance in hemolymph at the genus level after hemocyanin knockdown (48 hpi) with and without NAM treatment (24 hpi) followed by Vp infection (24 hpi) shown by (B) community bar plot of bacteria taxa proportions and (C) Student’s t-test bar plot at genus level (n = 3). (DE) Hemolymph microbial community diversity at the OTU level after hemocyanin knockdown with or without NAM supplementation followed by V. parahaemolyticus (Vp) infection using (D) Shannon diversity index and (E) principal coordinates analysis (PCoA). (F–H) the quantification of the (F) total bacterial abundance, (G) Vibrio abundance, and (H) Shewanella abundance using qPCR. (I) The NAD levels in shrimp plasma were determined by ELISA. (J–M) the quantification of the (J) total bacterial abundance, (K) Staphylococcus aureus, (L) Vibrio abundance, and (M) Shewanella abundance using qPCR after hemocyanin knockdown (48 hpi) with and without NAM treatment (24 hpi) followed by S. aureus (Sa) infection (24 hpi). Each dot represents an independent sample (n = 3), and results were reported as mean ± SEM. *P < .05, **P < .01.
We further asked whether this regulation also occurred during Gram-positive bacterial infection. After Staphylococcus aureus challenge, niacinamide supplementation did not significantly alter the abundances of total bacteria, S. aureus, or Vibrio, although Shewanella abundance was lower in dsLvHMC + Ns + Sa than in dsGFP + Ns + Sa (Fig. 4J–M). These results suggest that hemocyanin-dependent niacinamide regulation of hemolymph microbiota is more evident during V. parahaemolyticus infection than during S. aureus infection.
Niacinamide enhances shrimp survival during Vibrio parahaemolyticus infection
Finally, we assessed whether niacinamide affects shrimp survival after hemocyanin knockdown. Under physiological conditions, niacinamide modestly improved survival of hemocyanin-silenced shrimp (80.95% vs 66.67%; Fig. 5A). After V. parahaemolyticus infection, survival in the dsLvHMC + Ns group fell to 0% within 48 h, whereas niacinamide supplementation increased survival to 22.73% (Fig. 5B). In contrast, after S. aureus infection, niacinamide had only a limited effect on survival (25.00% vs 20.83%; Fig. 5C). These findings indicate that hemocyanin-mediated niacinamide regulation contributes to shrimp resistance to V. parahaemolyticus infection.
Figure 5.
Effect of niacinamide (NAM) supplementation on penaeid shrimp survival. Shrimp survival rate (A) after hemocyanin knockdown with and without NAM treatment under physiological conditions, and (B) after hemocyanin knockdown with and without NAM treatment followed by V. parahaemolyticus (Vp) or (C) S. aureus (Sa) infection was recorded. The product-limit method of Kaplan–Meier was used to calculate the shrimp survival rate and the significance compared using the log-rank test.
Discussion
Crustaceans possess a semi-open circulatory system in which hemolymph is continuously exposed to microorganisms from the surrounding aquatic environment [41, 42]. Under normal conditions, hemolymph microbiota are maintained in a relatively stable state, whereas environmental stress or pathogen invasion can disrupt this balance and promote the expansion of opportunistic bacteria [15, 42]. In the present study, we show that this homeostasis is closely linked to hemocyanin, the most abundant soluble protein in shrimp hemolymph. Diseased shrimp exhibited lower hemocyte hemocyanin expression, reduced niacinamide levels, and increased Vibrio abundance, while experimental hemocyanin knockdown reproduced these changes and further promoted the proliferation of Vibrio and Shewanella during V. parahaemolyticus challenge. These findings support a role for hemocyanin in maintaining hemolymph microbial balance under infection pressure.
Hemocyanin is best known as a respiratory protein, but accumulating evidence indicates that it also participates broadly in shrimp immune regulation [43–45]. Given that some metabolites play an essential role in maintaining microbiome homeostasis and impact host susceptibility to pathogenic microorganisms [5, 46] or enhance host immune surveillance [47], it is plausible that shrimp hemocyanin could affect metabolic processes in hemolymph to affect the microbiota since hemocyanin has previously been implicated in fatty acid metabolism [40] and energy metabolism [39] in the hepatopancreas. Thus, the current study explored the changes in metabolite profiles and the consequences on hemolymph microbiota composition in diseased and healthy penaeid shrimp, which expressed different levels of hemocyanin.
After metabolomic profiling of hemolymph samples from V. parahaemolyticus–infected and healthy penaeid shrimp, which expressed different levels of hemocyanin, six dysregulated metabolites (uric acid, phenylacetaldehyde, L-carnitine, N-acetylgalactosamine, niacinamide, and crustecdysone) that seem to play a crucial role in shrimp susceptibility to Vibrio were identified. Indeed, strong positive correlations were observed between the relative levels of hemocyanin and two key metabolites, i.e. uric acid and niacinamide, with the latter being the strongest (Fig. 2B). Niacinamide, which is an amide derivative of water-soluble vitamin B3, is regarded as a safe therapeutic agent for the treatment of various human diseases, including melanoma [48], diabetes mellitus [49], and Parkinson’s disease [50]. As a major precursor in the biosynthesis of NAD in mammalian cells [24], the conversion of niacinamide into niacinamide mononucleotide (NMN) through the salvage pathway constitutes the primary route by which NAD is produced [51]. On the other hand, NAD is a crucial substrate for essential enzymes, such as SIRT, PARP, and CD38 [25], which is used in metabolism and niacinamide production. In the present study, mRNA transcript levels of rate-limiting enzymes of the niacinamide salvage pathway, i.e. NRK1/2, NMNAT, ENPP1, and SIRT2/6, and plasma NAD levels were attenuated as a result of depleted hemocyanin (LvHMC) expression during V. parahaemolyticus infection. Moreover, LvHMC was found to interact with LvNRK1 (Fig. 2G), LvSIRT2, and LvSIRT6 (Fig. 2F-H), and this physical interaction was accompanied by a significant enhancement of the catalytic activities of these niacinamide salvage pathway enzymes (e.g. NRK1, SIRT2, SIRT6) (Fig. 2I and J), suggesting that hemocyanin modulates the niacinamide metabolism and hemocyanin depletion results in the niacinamide salvage pathway metabolism perturbation.
We found that penaeid shrimp (L. vannamei) in the same aquaculture pond that displayed characteristic symptoms (atrophied hepatopancreases with loose hepatic tubules and hemocytic infiltration, shedding of hepatic tubules, and empty GITs) of Vibrio infection [52, 53] had low hemocyte hemocyanin levels, coupled with negative correlation with Vibrio abundance (Fig. 3A–G). Interestingly, significantly lower levels of niacinamide were also found in the plasma of diseased shrimp compared with healthy shrimp (Fig. 3I), suggesting that niacinamide levels are modulated by hemocyanin to enhance shrimp resistance to Vibrio infection. Although there is currently limited information on the role of niacinamide in microbiota regulation, niacinamide has activity against a variety of pathogenic microorganisms, including Plasmodium falciparum [54], Mycobacterium tuberculosis [55], and Candida albicans [56]. Incubation of niacinamide with African Trypanosomiasis resulted in lysosome destruction, cytoplasmic division, and cell death [57]. Our data indicate that niacinamide supplementation significantly attenuates Vibrio levels caused by decreased hemocyanin expression under V. parahaemolyticus infection. Interestingly, the effects of hemocyanin on hemolymph homeostasis through niacinamide metabolism was induced by V. parahaemolyticus (Gram-negative bacteria), while the response to S. aureus (Gram-positive bacteria) was not significant (Fig. 4), suggesting that niacinamide may function as an antimicrobial metabolite against Gram-negative bacteria. In the hemolymph of most aquatic invertebrates, such as the Pacific oyster Crassostrea gigas [58], mud crab Scylla paramamosian [59], and scallop Argopecten purpuratus [13], the abundant and dominant bacterial genera are mainly Gram negative, with Vibrio being the most common opportunistic pathogen [60]. Thus, hemocyanin, shrimp’s most abundant plasma protein, may represent an innate immune strategy against Gram-negative bacteria exerted via niacinamide metabolism in crustaceans.
In conclusion, we revealed that hemocyanin modulates microbial composition in the hemolymph of penaeid shrimp during V. parahaemolyticus infection. The proposed mechanism supporting the current findings is that decreased hemocyanin levels induce the niacinamide salvage pathway metabolism perturbation, which consequently causes V. parahaemolyticus infection in penaeid shrimp (Fig. 6).
Figure 6.
Proposed schematic illustration of the mechanism by which hemocyanin-modulated niacinamide shapes the hemolymph microbiota in Vibrio-infected shrimp. Under normal conditions, LvHMC maintains the homeostasis of the nicotinamide salvage pathway. Knockdown of LvHMC level causes metabolic disorder of the nicotinamide salvage pathway, which further impairs the host immune defense and ultimately increases the susceptibility of L. vannamei to V. parahaemolyticus infection.
Supplementary Material
Contributor Information
Shiyuan Bao, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China; Key Laboratory of Tropical Marine Ecosystem and Bioresource, Fourth Institute of Oceanography, Ministry of Natural Resources, Beihai, Guangxi, 536000, China.
Mingming Jiang, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China.
Jude Juventus Aweya, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China; Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB, R2H 2A6, Canada; The Canadian Centre for Agri-Food Research in Health and Medicine, St Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB, R2H 2A6, Canada.
Yongsheng Zhang, Key Laboratory of Tropical Marine Ecosystem and Bioresource, Fourth Institute of Oceanography, Ministry of Natural Resources, Beihai, Guangxi, 536000, China.
Xianliang Zhao, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China.
Yongzhen Zhao, Guangxi Academy of Fishery Sciences, Guangxi Key Laboratory of Aquatic Genetic Breeding and Healthy Aquaculture, Nanning, Guangxi 530021, China.
Chunling Yang, Guangxi Academy of Fishery Sciences, Guangxi Key Laboratory of Aquatic Genetic Breeding and Healthy Aquaculture, Nanning, Guangxi 530021, China.
Shengkang Li, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China.
Zhihong Zheng, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China.
Yueling Zhang, Guangdong Provincial Key Laboratory of Marine Biotechnology, Institute of Marine Sciences, Shantou University, Shantou, Guangdong 515063, China.
Author contributions
Conceptualization: Y.L.Z., Z.H.Z., J.J.A., and S.Y.B. Funding acquisition: Y.L.Z. and Y.Z.Z. Investigation: S.Y. B., M.M.J., Z.H.Z., and Y.S.Z. Methodology: S.Y.B. Formal analysis: S.Y.B. Resources: Y.Z.Z., C.L.Y., and S.K.L. Supervision: Y.L.Z., Z.H.Z., S.K.L., and X.L.Z. Writing—original draft: S.Y. B. Writing—review and editing: J.J.A. and Y.L.Z. All authors have read and agreed to the published version of the manuscript.
Conflicts of interest
The authors have no conflicts of interest to declare.
Funding
This work was primarily supported by grants from the National Natural Science Foundation of China (No. U22A20536), Li Ka Shing Foundation Cross-Disciplinary Research Grant (No. 2020LKSFG01E), and Guangxi Science and Technology Major Special Project (No. AA23062046).
Data availability
The 16S rRNA gene sequencing data generated during this study are available at the NCBI Sequence Read Archive with BioProject accession numbers PRJNA988426, while all the metabolomic raw data are deposited to MetaboLights (http://www.ebi.ac.uk/metabolights/) with the unique identifier MTBLS8272.
References
- 1. Berding K, Vlckova K, Marx W et al. Diet and the microbiota–gut–brain axis: sowing the seeds of good mental health. Adv Nutr 2021;12:1239–85. 10.1093/advances/nmaa181 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Kayama H, Okumura R, Takeda K. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol 2020;38:23–48. 10.1146/annurev-immunol-070119-115104 [DOI] [PubMed] [Google Scholar]
- 3. Chen Y, Zhou J, Wang L. Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol 2021;11:625913. 10.3389/fcimb.2021.625913 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci 2019;76:473–93. 10.1007/s00018-018-2943-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016;16:341–52. 10.1038/nri.2016.42 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Ruff WE, Greiling TM, Kriegel MA. Host–microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020;18:521–38. 10.1038/s41579-020-0367-2 [DOI] [PubMed] [Google Scholar]
- 7. Castillo DJ, Rifkin RF, Cowan DA et al. The healthy human blood microbiome: fact or fiction? Front Cell Infect Microbiol 2019;9:148. 10.3389/fcimb.2019.00148 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Cohen C, Toh E, Munro D et al. Similarities and seasonal variations in bacterial communities from the blood of rodents and from their flea vectors. ISME J 2015;9:1662–76. 10.1038/ismej.2014.255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Potgieter M, Bester J, Kell DB et al. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 2015;39:567–91. 10.1093/femsre/fuv013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Velmurugan G, Dinakaran V, Rajendhran J et al. Blood microbiota and circulating microbial metabolites in diabetes and cardiovascular disease. Trends Endocrinol Metab 2020;31:835–47. 10.1016/j.tem.2020.01.013 [DOI] [PubMed] [Google Scholar]
- 11. Rodriguez-Brito B, Li L, Wegley L et al. Viral and microbial community dynamics in four aquatic environments. ISME J 2010;4:739–51. 10.1038/ismej.2010.1 [DOI] [PubMed] [Google Scholar]
- 12. Rathour R, Ma Y, Xiong J et al. Hemolymph microbiota and host immunity of crustaceans and mollusks. ISME J 2025;19:wraf133. 10.1093/ismejo/wraf133 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. González R, Gonçalves AT, Rojas R et al. Host defense effectors expressed by hemocytes shape the bacterial microbiota from the scallop hemolymph. Front Immunol 2020;11:599625. 10.3389/fimmu.2020.599625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Dupont S, Lokmer A, Corre E et al. Oyster hemolymph is a complex and dynamic ecosystem hosting bacteria, protists and viruses. Anim Microbiome 2020;2:12. 10.1186/s42523-020-00032-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Wang X-W, Wang J-X. Crustacean hemolymph microbiota: endemic, tightly controlled, and utilization expectable. Mol Immunol 2015;68:404–11. 10.1016/j.molimm.2015.06.018 [DOI] [PubMed] [Google Scholar]
- 16. Rajeev R, Adithya K, Kiran GS et al. Healthy microbiome: a key to successful and sustainable shrimp aquaculture. Rev Aquac 2021;13:238–58. 10.1111/raq.12471 [DOI] [Google Scholar]
- 17. Zhang X, Zhang M, Zheng H et al. Source of hemolymph microbiota and their roles in the immune system of mud crab. Dev Comp Immunol 2020;102:103470. 10.1016/j.dci.2019.103470 [DOI] [PubMed] [Google Scholar]
- 18. Tassanakajon A, Rimphanitchayakit V, Visetnan S et al. Shrimp humoral responses against pathogens: antimicrobial peptides and melanization. Dev Comp Immunol 2018;80:81–93. 10.1016/j.dci.2017.05.009 [DOI] [PubMed] [Google Scholar]
- 19. De la Ballina NR, Maresca F, Cao A et al. Bivalve haemocyte subpopulations: a review. Front Immunol 2022;13:826255. 10.3389/fimmu.2022.826255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Wang X-W, Gao J, Xu Y-H et al. Novel pattern recognition receptor protects shrimp by preventing bacterial colonization and promoting phagocytosis. J Immunol 2017;198:3045–57. 10.4049/jimmunol.1602002 [DOI] [PubMed] [Google Scholar]
- 21. Huang Y, Ren Q. Research progress in innate immunity of freshwater crustaceans. Dev Comp Immunol 2020;104:103569. 10.1016/j.dci.2019.103569 [DOI] [PubMed] [Google Scholar]
- 22. MK Jacobson, EL Jacobson. Vitamin B3 in health and disease: toward the second century of discovery. In: Chang, P. (eds) ADP-Ribosylation and NAD+ Utilizing Enzymes: Methods in Molecular Biology. 2018;1813:3–8. 10.1007/978-1-4939-8588-3_1 [DOI] [PubMed] [Google Scholar]
- 23. Yoshino J, Baur JA, Imai S-i. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab 2018;27:513–28. 10.1016/j.cmet.2017.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Campbell JM. Supplementation with NAD+ and its precursors to prevent cognitive decline across disease contexts. Nutrients 2022;14:3231. 10.3390/nu14153231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Navas LE, Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther 2021;6:2. 10.1038/s41392-020-00354-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Sidhu A, Diwan V, Kaur H et al. Nicotinamide reverses behavioral impairments and provides neuroprotection in 3—nitropropionic acid induced animal model of Huntington’s disease: implication of oxidative stress– poly(ADP– ribose) polymerase pathway. Metab Brain Dis 2018;33:1911–21. 10.1007/s11011-018-0297-0 [DOI] [PubMed] [Google Scholar]
- 27. Grange PA, Raingeaud J, Calvez V et al. Nicotinamide inhibits Propionibacterium acnes-induced il-8 production in keratinocytes through the NF-κB and MAPK pathways. J Dermatol Sci 2009;56:106–12. 10.1016/j.jdermsci.2009.08.001 [DOI] [PubMed] [Google Scholar]
- 28. Ieraci A, Herrera DG. Nicotinamide inhibits ethanol-induced caspase-3 and PARP-1 over-activation and subsequent neurodegeneration in the developing mouse cerebellum. Cerebellum 2018;17:326–35. 10.1007/s12311-017-0916-z [DOI] [PubMed] [Google Scholar]
- 29. Rehman IU, Ahmad R, Khan I et al. Retracted: Nicotinamide ameliorates amyloid beta-induced oxidative stress-mediated neuroinflammation and neurodegeneration in adult mouse brain. Biomedicines 2021;9:408. 10.3390/biomedicines9040408 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 30. Hashimoto T, Perlot T, Rehman A et al. Ace2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012;487:477–81. 10.1038/nature11228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Prithvisagar KS, Krishna Kumar B, Kodama T et al. Whole genome analysis unveils genetic diversity and potential virulence determinants in Vibrio parahaemolyticus associated with disease outbreak among cultured Litopenaeus vannamei (Pacific white shrimp) in India. Virulence 2021;12:1936–49. 10.1080/21505594.2021.1947448 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Cornejo-Granados F, Lopez-Zavala AA, Gallardo-Becerra L et al. Microbiome of pacific whiteleg shrimp reveals differential bacterial community composition between wild, aquacultured and AHPND/EMS outbreak conditions. Sci Rep 2017;7:11783. 10.1038/s41598-017-11805-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Holt CC, Bass D, Stentiford GD et al. Understanding the role of the shrimp gut microbiome in health and disease. J Invertebr Pathol 2021;186:107387. [DOI] [PubMed] [Google Scholar]
- 34. Dong P, Guo H, Wang Y et al. Gastrointestinal microbiota imbalance is triggered by the enrichment of Vibrio in subadult Litopenaeus vannamei with acute hepatopancreatic necrosis disease. Aquaculture 2021;533:736199. [Google Scholar]
- 35. Li C, Hong P-P, Yang M-C et al. FOXO regulates the expression of antimicrobial peptides and promotes phagocytosis of hemocytes in shrimp antibacterial immunity. PLoS Pathog 2021;17:e1009479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Wang X-W, Xu J-D, Zhao X-F et al. A shrimp c-type lectin inhibits proliferation of the hemolymph microbiota by maintaining the expression of antimicrobial peptides. J Biol Chem 2014;289:11779–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Sellos D, Lemoine S, Van Wormhoudt A. Molecular cloning of hemocyanin cDNA from Penaeus vannamei (Crustacea, Decapoda): structure, evolution and physiological aspects. FEBS Lett 1997;407:153–8. 10.1016/S0014-5793(97)00350-5 [DOI] [PubMed] [Google Scholar]
- 38. Li J, Zhao M, Zhang X et al. The evolutionary adaptation of shrimp hemocyanin subtypes and the consequences on their structure and functions. Fish Shellfish Immunol 2024;145:109347. 10.1016/j.fsi.2023.109347 [DOI] [PubMed] [Google Scholar]
- 39. Zheng Z, Aweya JJ, Bao S et al. The microbial composition of penaeid shrimps’ hepatopancreas is modulated by hemocyanin. J Immunol 2021;207:2733–43. 10.4049/jimmunol.2100746 [DOI] [PubMed] [Google Scholar]
- 40. Aweya JJ, Zheng X, Zheng Z et al. The sterol regulatory element binding protein homolog of Penaeus vannamei modulates fatty acid metabolism and immune response. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158757. [DOI] [PubMed] [Google Scholar]
- 41. Söderhäll I. Crustacean hematopoiesis. Dev Comp Immunol 2016;58:129–41. 10.1016/j.dci.2015.12.009 [DOI] [PubMed] [Google Scholar]
- 42. Kong T, Fan X, Tran NT. Changes in hemolymph microbiota of Chinese mitten crab (Eriocheir sinensis) in response to Aeromonas hydrophila or Staphylococcus aureus infection. Animals 2023;13:3058. 10.3390/ani13193058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Aweya JJ, Zhuang K, Liu Y et al. The ARM repeat domain of hemocyanin interacts with MKK4 to modulate antimicrobial peptides expression. Iscience 2022;25:103958. 10.1016/j.isci.2022.103958 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Zhao X, Qiao J, Zhang P et al. Protein diversity and immune specificity of hemocyanin from shrimp Litopenaeus vannamei. Front Immunol 2021;12:772091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Coates CJ, Decker H. Immunological properties of oxygen-transport proteins: hemoglobin, hemocyanin and hemerythrin. Cell Mol Life Sci 2017;74:293–317. 10.1007/s00018-016-2326-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Wang G, Huang S, Wang Y et al. Bridging intestinal immunity and gut microbiota by metabolites. Cell Mol Life Sci 2019;76:3917–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Nagao-Kitamoto H, Leslie JL, Kitamoto S et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat Med 2020;26:608–17. 10.1038/s41591-020-0764-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Scatozza F, Moschella F, D’Arcangelo D et al. Nicotinamide inhibits melanoma in vitro and in vivo. J Exp Clin Cancer Res 2020;39:211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Maiese K. Nicotinamide as a foundation for treating neurodegenerative disease and metabolic disorders. Curr Neurovasc Res 2021;18:134–49. 10.2174/18755739MTEzaMDMw2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Schöndorf DC, Ivanyuk D, Baden P et al. The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease. Cell Rep 2018;23:2976–88. 10.1016/j.celrep.2018.05.009 [DOI] [PubMed] [Google Scholar]
- 51. Cantó C, Menzies KJ, Auwerx J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 2015;22:31–53. 10.1016/j.cmet.2015.05.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Ajadi A, Sabri M, Dauda AB et al. Immunoprophylaxis: a better alternative protective measure against shrimp vibriosis-a review. PJSRR 2016;2:58–69. [Google Scholar]
- 53. Tran L, Nunan L, Redman RM et al. Determination of the infectious nature of the agent of acute hepatopancreatic necrosis syndrome affecting penaeid shrimp. Dis Aquat Org 2013;105:45–55. 10.3354/dao02621 [DOI] [PubMed] [Google Scholar]
- 54. Tcherniuk SO, Chesnokova O, Oleinikov IV et al. Nicotinamide inhibits the growth of P. falciparum and enhances the antimalarial effect of artemisinin, chloroquine and pyrimethamine. Mol Biochem Parasitol 2017;216:14–20. 10.1016/j.molbiopara.2017.06.004 [DOI] [PubMed] [Google Scholar]
- 55. Murray MF. Nicotinamide: an oral antimicrobial agent with activity against both mycobacterium tuberculosis and human immunodeficiency virus. Clin Infect Dis 2003;36:453–60. [DOI] [PubMed] [Google Scholar]
- 56. Xing X, Liao Z, Tan F et al. Effect of nicotinamide against Candida albicans. Front Microbiol 2019;10:595. 10.3389/fmicb.2019.00595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Unciti-Broceta JD, Maceira J, Morales S et al. Nicotinamide inhibits the lysosomal cathepsin b-like protease and kills African trypanosomes. J Biol Chem 2013;288:10548–57. 10.1074/jbc.M112.449207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Lokmer A, Goedknegt MA, Thieltges DW et al. Spatial and temporal dynamics of Pacific oyster hemolymph microbiota across multiple scales. Front Microbiol 2016;7:1367. 10.3389/fmicb.2016.01367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Gong Y, Wei X, Sun W et al. Exosomal miR-224 contributes to hemolymph microbiota homeostasis during bacterial infection in crustacean. PLoS Pathog 2021;17:e1009837. 10.1371/journal.ppat.1009837 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Destoumieux-Garzón D, Canesi L, Oyanedel D et al. Vibrio–bivalve interactions in health and disease. Environ Microbiol 2020;22:4323–41. 10.1111/1462-2920.15055 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The 16S rRNA gene sequencing data generated during this study are available at the NCBI Sequence Read Archive with BioProject accession numbers PRJNA988426, while all the metabolomic raw data are deposited to MetaboLights (http://www.ebi.ac.uk/metabolights/) with the unique identifier MTBLS8272.






